Having trouble accessing articles? Reset your cache.

Lurbinectedin: Completed Phase II enrollment

PharmaMar completed enrollment of 59 patients in the Phase IIb portion of an open-label Phase II trial comparing PM01183 vs. topotecan, bringing total enrollment to

Read the full 253 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE